According to Microbot Medical 's latest financial reports and stock price the company's current Operating Margin is -31,154.00%. At the end of 2015 the company had an Operating Margin of -31,154.04%.
Year | Operating Margin | Change |
---|---|---|
2015 | -31,154.04% | 877.66% |
2014 | -3,186.58% | 45.02% |
2013 | -2,197.28% | 5.5% |
2012 | -2,082.76% | -6.3% |
2011 | -2,222.90% | 8.86% |
2010 | -2,041.91% | -30.99% |
2009 | -2,958.92% | -73.5% |
2008 | -11,164.65% | -77.23% |
2007 | -49,025.33% | 113% |
2006 | -23,016.51% | 189.2% |
2005 | -7,958.70% | -27.11% |
2004 | -10,919.24% | 145.81% |
2003 | -4,442.17% | 80.72% |
2002 | -2,458.03% | 70.83% |
2001 | -1,438.84% |
Company | Operating Margin | Operating Margin differencediff. | Country |
---|---|---|---|
Nymox Pharmaceutical NYMX | -234,760.00% | 653.55% | Bahamas |
NRC Health
NRC | 32.86% | -100.11% | ๐บ๐ธ USA |
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.